Peter Schauwecker

Results of Intracoronary Stem Cell Therapy After Acute Myocardial Infarction

Jochen Wöhrle, Nico Merkle, Volker Mailänder et al. · The American Journal of Cardiology · 2010 · 116 citations

Regenerative Medicine, Cell Therapy, Cellular Therapies +11

¹⁸⁸Re or ⁹⁰Y‐labelled anti‐CD66 antibody as part of a dose‐reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study

Mark Ringhoffer, Norbert M. Blumstein, Bernd Neumaier et al. · British Journal of Haematology · 2005 · 89 citations · Full text

Modulation of Cell Death by Mouse Genotype: Differential Vulnerability to Excitatory Amino Acid-Induced Lesions

Peter Schauwecker · Experimental Neurology · 2002 · 68 citations

Knockout Mouse, Molecular Neuroscience, Mouse Genotype +10

Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial

Jochen Wöhrle, Fabian von Scheidt, Peter Schauwecker et al. · Clinical Research in Cardiology · 2013 · 56 citations

Thrombosis, Cell Therapy, Cardiovascular Disease +9

Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol.

Reinhard W. Holl, U. Schwarz, Peter Schauwecker et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 49 citations

Human Growth, Female Reproductive Function, Reproductive Biology +17